133 related articles for article (PubMed ID: 22479892)
21. [Evaluation of ambroxol given prenatally and postnatally on gas exchange in the newborn with respiratory distress syndrome].
Sackey S; Gadzinowski J; Szymankiewicz M; Breborowicz GH; Rudnicki J; Patalan J; Rózewicki K
Ginekol Pol; 1995 Jul; 66(7):409-12. PubMed ID: 8655006
[TBL] [Abstract][Full Text] [Related]
22. [Prenatal prevention of infant respiratory distress syndrome. 2nd part: clinical applications and indications].
Lenclen R; Paupe A; Philippe HJ; Olivier-Martin M; Nisand I
J Gynecol Obstet Biol Reprod (Paris); 1995; 24(3):294-309. PubMed ID: 7622778
[TBL] [Abstract][Full Text] [Related]
23. First intention high-frequency oscillatory and conventional mechanical ventilation in premature infants without antenatal glucocorticoid prophylaxis.
Salvo V; Zimmermann LJ; Gavilanes AW; Barberi I; Ricotti A; Abella R; Frigiola A; Giamberti A; Florio P; Tagliabue P; Tina LG; Nigro F; Temporini F; Gazzolo D
Pediatr Crit Care Med; 2012 Jan; 13(1):72-9. PubMed ID: 21499177
[TBL] [Abstract][Full Text] [Related]
24. Antenatal thyrotropin-releasing hormone to prevent lung disease in preterm infants. North American Thyrotropin-Releasing Hormone Study Group.
Ballard RA; Ballard PL; Cnaan A; Pinto-Martin J; Davis DJ; Padbury JF; Phibbs RH; Parer JT; Hart MC; Mannino FL; Sawai SK
N Engl J Med; 1998 Feb; 338(8):493-8. PubMed ID: 9468465
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of a single dose of antenatal corticosteroids on morbidity and mortality of preterm infants.
Costa S; Zecca E; De Luca D; De Carolis MP; Romagnoli C
Eur J Obstet Gynecol Reprod Biol; 2007 Apr; 131(2):154-7. PubMed ID: 16797825
[TBL] [Abstract][Full Text] [Related]
26. Changes in neonatology: comparison of two cohorts of very preterm infants (gestational age <32 weeks): the Project On Preterm and Small for Gestational Age Infants 1983 and the Leiden Follow-Up Project on Prematurity 1996-1997.
Stoelhorst GM; Rijken M; Martens SE; Brand R; den Ouden AL; Wit JM; Veen S;
Pediatrics; 2005 Feb; 115(2):396-405. PubMed ID: 15689337
[TBL] [Abstract][Full Text] [Related]
27. [Perinatal glucocorticosteroid therapy: time for reconsideration].
Groneck P
Z Geburtshilfe Neonatol; 2001; 205(6):231-5. PubMed ID: 11745009
[TBL] [Abstract][Full Text] [Related]
28. Antenatal maternal medication administration in preventing respiratory distress syndrome of premature infants: A network meta-analysis.
Zhang H; Liu J; Liu T; Wang Y; Dai W
Clin Respir J; 2018 Oct; 12(10):2480-2490. PubMed ID: 30074296
[TBL] [Abstract][Full Text] [Related]
29. [Value of prenatal corticotherapy in the prevention of hyaline membrane disease in premature infants. Randomized prospective study].
Fekih M; Chaieb A; Sboui H; Denguezli W; Hidar S; Khairi H
Tunis Med; 2002 May; 80(5):260-5. PubMed ID: 12534029
[TBL] [Abstract][Full Text] [Related]
30. Requirements of perinatal prevention and treatment of respiratory distress syndrome.
Di Renzo GC; Anceschi MM; Guidetti R; Cosmi EV
Eur Respir J Suppl; 1989 Mar; 3():68s-72s. PubMed ID: 2662998
[TBL] [Abstract][Full Text] [Related]
31. Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Ross Collaborative Surfactant Prevention Study Group.
Soll RF; Hoekstra RE; Fangman JJ; Corbet AJ; Adams JM; James LS; Schulze K; Oh W; Roberts JD; Dorst JP
Pediatrics; 1990 Jun; 85(6):1092-102. PubMed ID: 2187176
[TBL] [Abstract][Full Text] [Related]
32. Morphine administration and short-term pulmonary outcomes among ventilated preterm infants.
Bhandari V; Bergqvist LL; Kronsberg SS; Barton BA; Anand KJ;
Pediatrics; 2005 Aug; 116(2):352-9. PubMed ID: 16061589
[TBL] [Abstract][Full Text] [Related]
33. [Ambroxol].
Akkoca Yildiz O
Tuberk Toraks; 2006; 54 Suppl 1():3-14. PubMed ID: 17089236
[No Abstract] [Full Text] [Related]
34. Decreased respiratory compliance in infants less than or equal to 32 weeks' gestation, delivered more than 7 days after antenatal steroid therapy.
McEvoy C; Schilling D; Spitale P; Peters D; O'Malley J; Durand M
Pediatrics; 2008 May; 121(5):e1032-8. PubMed ID: 18450845
[TBL] [Abstract][Full Text] [Related]
35. Changes in pulmonary function in preterm infants recovering from RDS following early treatment with ambroxol: results of a randomized trial.
Schmalisch G; Wauer RR; Böhme B
Pediatr Pulmonol; 1999 Feb; 27(2):104-12. PubMed ID: 10088933
[TBL] [Abstract][Full Text] [Related]
36. [Dilemmas about the antenatal use of corticosteroids for prevention of neonatal morbidity and mortality].
Grgić O; Matijević R
Acta Med Croatica; 2005; 59(2):129-35. PubMed ID: 15909887
[TBL] [Abstract][Full Text] [Related]
37. [Ambroxol versus betamethasone for the promotion of antepartum lung maturity in pathological pregnancies].
Heytmanek G; Salzer H; Vityska-Binstorfer E; Genger H; Metka M; Pfersmann R; Wolff F; Weidinger H
Wien Klin Wochenschr; 1990 Aug; 102(15):443-8. PubMed ID: 2402930
[TBL] [Abstract][Full Text] [Related]
38. Antenatal corticosteroid therapy in premature infants.
Smrcek JM; Schwartau N; Kohl M; Berg C; Geipel A; Krapp M; Diedrich K; Ludwig M
Arch Gynecol Obstet; 2005 Jan; 271(1):26-32. PubMed ID: 15309401
[TBL] [Abstract][Full Text] [Related]
39. Is it safer to intubate premature infants in the delivery room?
Aly H; Massaro AN; Patel K; El-Mohandes AA
Pediatrics; 2005 Jun; 115(6):1660-5. PubMed ID: 15930230
[TBL] [Abstract][Full Text] [Related]
40. One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials.
Moya F; Sinha S; Gadzinowski J; D'Agostino R; Segal R; Guardia C; Mazela J; Liu G;
Pediatrics; 2007 Jun; 119(6):e1361-70. PubMed ID: 17533176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
